BRD9 and rhabdoid tumor: In SMARCB1-null rhabdoid tumors, the presence of BRG1 and the non-canonical SWI/SNF subunit, BRD9, are synthetic lethal targets in rhabdoid cancers [14,44], although the mechanisms by which they maintain a rogue gene expression program are not entirely clear.